Wyndham Hotels director boosts stake with routine stock grants

Rhea-AI Filing Summary

Wyndham Hotels & Resorts (WH) – Form 4 filed 29 Jul 2025

Independent director Myra J. Biblowit disclosed two routine equity grants dated 25 Jul 2025:

• 353 common shares issued for quarterly board retainer at an indicated value of $92 per share, bringing her directly held common-stock position to 13,434 shares.
• 404 deferred stock units (DSUs) credited for dividend equivalents at the same $92 valuation. Total DSUs now equal 90,978; each converts into one share upon the director’s departure from the board.
• She also reports ownership of 3,511 restricted stock units.

No sales or derivative exercises occurred. The filing reflects standard non-cash director compensation rather than discretionary open-market buying, so monetary impact on WH is de-minimis. Nevertheless, continued accumulation, coupled with an absence of dispositions, modestly reinforces board-shareholder alignment.

Insights

Securities Analyst

TL;DR – Routine director equity grant; no market-moving impact.

The Form 4 shows Ms. Biblowit receiving 757 equity units (353 shares, 404 DSUs) worth roughly US$69k at the reference price of $92. Her total beneficial exposure now exceeds 108k share equivalents, but the grants are part of Wyndham’s regular quarterly board compensation and involve no cash outlay by the director. There are no sales or derivative trades that might signal sentiment change. Because the amounts are immaterial versus WH’s ~90 m share float and do not alter governance structure, the filing is best viewed as neutral from a valuation standpoint, though continued retention of shares is marginally shareholder-friendly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BIBLOWIT MYRA J

(Last) (First) (Middle)

WYNDHAM HOTELS & RESORTS, INC.

22 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WYNDHAM HOTELS & RESORTS, INC. [ WH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/25/2025		A		353(1)	A	$92	13,434(2)	D
Common Stock	07/25/2025		A		404(3)	A	$92	90,978(4)	D
Common Stock								3,511(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Common stock issued for quarterly retainer fees.

2. Represents shares of common stock.

3. Deferred stock units issued for quarterly dividends. Each deferred stock unit entitles the reporting person to receive one share of common stock following the reporting person's retirement or termination of service from the Board of Directors.

4. Represents deferred stock units.

5. Represents restricted stock units.

Remarks:

	/s/ Paul F. Cash as Attorney-in-Fact for Myra J. Biblowit	07/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Wyndham Hotels (WH) shares did Director Biblowit acquire on 25 Jul 2025?

353 common shares were issued as part of her quarterly board retainer.

What are deferred stock units (DSUs) reported in the WH Form 4?

DSUs are bookkeeping entries; each unit converts into one WH share when the director leaves the board.

What is Director Biblowit’s total WH equity exposure after the transactions?

She now holds 13,434 common shares, 90,978 DSUs, and 3,511 RSUs.

Did the Form 4 include any sales of WH shares?

No. The filing only reports acquisitions tied to compensation; no shares were sold.

Is the reported $92 price an open-market purchase price?

No. The $92 value is a reference for the non-cash equity grants; the shares were issued by the company, not bought on the market.